The effect of teas on the in vitro mutagenic potential of heterocyclic aromatic amines

Food and Chemical Toxicology

Volumn 34, Issue 6, 1996, Pages 515-523

  Stavric, B ^a   Matula, T I ^b   Klassen, R ^a   Downie, R H ^b  

^a FOOD RESEARCH DIVISION   (Canada)

^b HEALTH CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

3 AMINO 1 METHYL 5H PYRIDO[4,3 B]INDOLE; ANTIMUTAGENIC AGENT; AROMATIC AMINE; HETEROCYCLIC AMINE;

AMES TEST; ARTICLE; CONTROLLED STUDY; IN VITRO STUDY; MUTAGENIC ACTIVITY; MUTAGENICITY; NONHUMAN; TEA;

CAMELLIA SINENSIS; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 0030176205     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-6915(96)00014-2     Document Type: Article

References (47)

1. Apostolides Z. and Weisburger J. H. (1995) Screening of tea clones for inhibition of PhIP mutagenicity. Mutation Research 326, 219-225.
2. Bu-Abbas A., Clifford M. N., Walker R. and Ioannides C. (1994) Marked antimutagenic potential of aqueous green tea extracts: mechanism of action. Mutagenesis 9, 325-331.
3. der Marderosian A. and Liberti L. E. (1988) Herbal teas: benefits and hazards. In Natural Product Medicine. A Scientific Guide to Foods, Drugs, Cosmetics. pp. 93-110. George F. Stickley Co., Philadelphia, PA.
4. Felton J. S., Knize M. G., Shen N. H. and Turteltaub K. W. (1992) Chemical analysis, prevention, and low-level dosimetry of heterocyclic amines from cooked food. Cancer Research (Suppl.) 52, 2103s-2107s.
5. Fujiki H., Yoshizawa S., Horiuchi T., Suganuma M., Yatsunami J., Nishiwaki S., Okabe S., Nishiwaki-Matsushima R., Okuda T. and Sugimura T. (1992) Anticarcinogenic effects of (-)epigallocatechin gallate. Preventive Medicine 21, 503-509.
6. Gao Y. T., McLaughlin J. K., Blot W. J., Ji B. T., Dai Q. and Fraumeni J. R., Jr (1994) Reduced risk of oesophageal cancer associated with green tea consumption. Journal of the National Cancer Institute 86, 855-858.
7. Gordon D. W., Rosenthal G., Hart J., Sirota R. and Baker A. L. (1995) Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications. Journal of the American Medical Association 273, 489-490.
8. Graham H. N. (1992) Green tea composition, consumption and polyphenol chemistry. Preventive Medicine 21, 334-350.
9. Ho C.-T., Chen Q., Shi H., Zhang K.-Q. and Rosen R. T. (1992) Antioxidative effect of polyphenol extract prepared from various Chinese teas. Preventive Medicine 21, 520-525.
10. IARC (1986) IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, Vol. 38. Tobacco Smoking. International Agency for Research on Cancer, Lyon.
11. IARC (1991) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 51. Coffee, Tea, Maté, Methylxanthines, and Methylglyoxal. pp. 1-513. International Agency for Research on Cancer, Lyon.
12. Ito Y., Ohnishi S. and Fujie K. (1989) Chromosome aberrations induced by aflatoxin B1 in rat bone marrow cells in vivo and their suppression by green tea. Mutation Research 222, 253-261.
13. Jain A. K., Shimoi K., Nakamura Y., Kada T., Hara Y. and Tomita I. (1989) Crude tea extracts decrease the mutagenic activity of N-methyl-N′-nitro-N-nitrosoguanidine in vitro and in intragastric tract of rats. Mutation Research 210, 1-8.
14. Joint Iran-International Agency for Research on Cancer Study Group (1977) Oesophageal cancer studies in the Caspian littoral of Iran: results of population studies - a prodrome. Journal of the National Cancer Institute 59, 1127-1138.
15. Klaunig J. E. (1992) Chemopreventive effects of green tea components on hepatic carcinogenesis. Preventive Medicine 21, 510-519.
16. Koff R. S. (1995) Herbal hepatotoxicity: revisiting a dangerous alternative (editorial). Journal of the American Medical Association 273, 502.
17. Kono S., Shinchi K., Ikeda N., Yanai F, and Imanishi K. (1992) Green tea consumption and serum lipid profiles: a cross-sectional study in Northern Kyushu, Japan. Preventive Medicine 21, 526-531.
18. Larrey D., Vial T., Pauwels A., Castot A., Biour M., David M. and Michel H. (1992) Hepatitis after germander (Teucrium chamaedrys) administration. Annals of Internal Medicine 117, 129-132.
19. Macgregor F. B., Abernethy V. E., Dahabra S., Cobden I. and Hayes P. C. (1989) Hepatotoxicity of herbal remedies. British Medical Journal 299, 1156-1157.
20. Maron D. M. and Ames B. N. (1983) Revised methods for the Salmonella mutagenicity test. Mutation Research 113, 173-215.
21. Matula T. I., Stavric B., Klassen R. and Downie R. H. (1986) Mutagenicity studies of coffee extracts in the Salmonella assay. Environmental Mutagenesis 8, 52.
22. Mukhtar H., Katiyar S. K. and Agarwal R. (1994) Green tea and skin - anticarcinogenic effects. Journal of Investigative Dermatology 102, 3-7.
23. Mukhtar H., Wang Z. Y., Katiyar S. K. and Agarwal R. (1992) Tea components: antimutagenic and anticarcinogenic effects. Preventive Medicine 21, 351-360.
24. Sagesaka-Mitane Y., Miwa M. and Okada S. (1990) Platelet aggregation inhibitors in hot water extract of green tea. Chemical Pharmaceutical Bulletin 38, 790-793.
25. Segi M. (1975) Tea-gruel as a possible factor for cancer of the oesophagus. Gann 66, 199-202.
26. Serafini A., Ghiselli A. and Ferro-Luzzi A. (1994) Red wine, tea, and antioxidants. Lancet 344, 626.
27. Shi S. T., Wang Z.-Y., Smith T. J., Hong J.-Y., Chen W.-F., Ho C.-T. and Yang C. S. (1994) Effects of green tea and black tea on 4-(methylnitroso)-1-(3-pyridyl)-1-butanone bioactivation, DNA methylation, and lung tumorigenesis in A/J mice. Cancer Research 54, 4641-4647.
28. Stampfer M. J. and Rimm E. B. (1993) A review of the epidemiology of dietary antioxidants and risk of coronary artery disease. Canadian Journal of Cardiology 9 (Suppl. B), 14B-18B.
29. Stavric B. (1994a) Role of chemopreventers in human diet. Clinical Biochemistry 27, 319-332.
30. Stavric B. (1994b) Biological significance of trace levels of mutagenic heterocyclic aromatic amines in human diet: a critical review. Food and Chemical Toxicology 32, 977-994.
31. Stavric B., Klassen R., Matula T. I. and Downie R. H. (1994) Tea inhibits the mutagenic activity of heterocyclic aromatic amines (HAAs). Ottawa Life Sciences Week, Ottawa Life Sciences Conference, Ottawa, Ontario, pp. 26-27. The Ottawa Life Sciences Council, Ottawa, Ontario, Canada.
32. Stavric B, and Matula T. I. (1992) Flavonoids in foods: their significance for nutrition and health. In Lipid Soluble Antioxidants: Biochemistry and Clinical Applications. Edited by A. S. H. Ong and L. Packer, pp. 274-294. Birkhaser Verlag, Basel.
33. Stavric B., Matula T. I., Klassen R. and Downie R. H. (1990) Inhibitory effect of flavonoids against mutagenic and carcinogenic xenobiotics in foods. In Flavonoids in Biology and Medicine III. Current Issues in Flavonoids Research. Edited by N. P. Das. pp. 515-528. National University of Singapore, Singapore.
34. Stavric B., Matula T. I., Klassen R. and Downie R. H. (1993) Analysis of commercial bouillons for trace levels of mutagens. Food and Chemical Toxicology 31, 981-987.
35. Stavric B., Matula T. I., Klassen R. and Downie R. H. (1995) Evaluation of hamburgers and hot dogs for the presence of mutagens. Food and Chemical Toxicology 33, 815-820.
36. Stensvold I., Tverdal A., Solvoll K. and Foss O. P. (1992) Tea consumption, relationship to cholesterol, blood pressure, and coronary and total mortality. Preventive Medicine 21, 546-553.
37. Stich H. F. (1992) Teas and tea components as inhibitors of carcinogen formation in model systems and man. Preventive Medicine 21, 377-384.
38. Sugimura T., Wakabayashi K., Nagao M. and Ohgaki H. (1989) Heterocyclic amines in cooked food. In Food Toxicology. A Perspective on the Relatives Risks. Edited by S. L. Taylor and R. A. Scanlan. pp. 31-35. Marcel Dekker, New York.
39. Tikkanen L. M., Sauri T. M. and Latva-Kala K. J. (1993) Screening of heat-processed Finnish foods for the mutagens 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Food and Chemical Toxicology 31, 717-721.
40. Wang Z. Y., Cheng S. J., Zhou Z. C., Athar M., Khan W. A., Bickers D. R. and Mukhtar H. (1989) Antimutagenic activity of green tea polyphenols. Mutation Research 223, 273-285.
41. Wang Z. Y., Huang M.-T., Lou Y.-R., Xie J.-G., Reuhl K. R., Newmark H. L., Ho C.-T., Yang C. S. and Conney A. H. (1994) Inhibitory effects of black tea, green tea, decaffeinated black tea, and decaffeinated green tea on ultraviolet B light-induced skin carcinogenesis in 7,12-dimethylbenz(a)anthracene-initiated SKH-1 mice. Cancer Research 54, 3428-3435.
42. Weisburger J. H. (1996) Tea antioxidants and health. In Handbook of Antioxidants. Edited by E. Cadenas and L. Packer. Marcel Dekker, New York. In press.
43. Yamada J. and Tomita Y. (1993) Enhancing effect of ascorbic acid on the mutagenicity of Trp-P-1 by indigocarmine in the Salmonella microsome. Biosciences, Biotechnology and Biochemistry 57, 117-118.
44. Yamada J. and Tomita Y. (1994) Antimutagenic activity of water extracts of black tea and oolong tea. Biosciences, Biotechnology and Biochemistry 58, 2197-2200.
45. Yamane T., Hagiwara N., Tateishi M., Akachi S., Kim M., Okuzumi J., Kitao Y., Inagake M., Kuwata K. and Takahashi T. (1991) Inhibition of azoxymethane-induced colon carcinogenesis in rat by green tea polyphenol fraction. Japanese Journal of Cancer Research 82, 1336-1339.
46. Yang S. C. and Wang Z.-Y. (1993) Tea and cancer. Journal of the National Cancer Institute 85, 1038-1049.
47. Yen G.-C. and Chen H.-Y. (1995) Antioxidant activity of various tea extracts in relation to their antimutagenicity. Journal of Agricultural and Food Chemistry 43, 27-32.